Bristol-Myers Squibb Co.

NYS : BMY
Pharmaceuticals
New York NY
2013 Revenue (US$ Millions)$16,385
2012 Revenue (US$ Millions)$17,621
Revenue Growth (%)-7.01%
Net Income (US$ Millions)$2,563
Common Shares Outstanding (Millions)$1,649
Earnings Per Share (US$)$1.54
Price To Earnings Ratio53.84
Total Equity (US$ Millions)$15,154
Profit Margin (%)15.64%
Return On Equity (%)18.81%
Long Term Debt (US$ Millions)$7,981
Debt To Equity Ratio (%)0.53%
Market Capitalization (US$ Millions)$87,644
Total Assets (US$ Millions)$38,592
Return on Assets (%)7.14
Current Assets (US$ Millions)$18,916
Inventories (US$ Millions)$1,498
Current Liabilities (US$ Millions)$12,440
Cost of Goods Sold (US$ Millions)$4,619
Asset Turnover0.42
Inventory Turnover2.93
ExchangeNYS